0001411920-12-000003.txt : 20120530 0001411920-12-000003.hdr.sgml : 20120530 20120530140345 ACCESSION NUMBER: 0001411920-12-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20120530 DATE AS OF CHANGE: 20120530 EFFECTIVENESS DATE: 20120530 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IRX Therapeutics, Inc. CENTRAL INDEX KEY: 0001411920 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-178994 FILM NUMBER: 12876944 BUSINESS ADDRESS: STREET 1: 140 W 57th St STREET 2: SUITE 9C CITY: New York STATE: NY ZIP: 10019 BUSINESS PHONE: 212-582-1199 MAIL ADDRESS: STREET 1: 140 W 57th St STREET 2: SUITE 9C CITY: New York STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: IRX Therapeutics Inc DATE OF NAME CHANGE: 20070910 D 1 primary_doc.xml X0705 D LIVE 0001411920 IRX Therapeutics, Inc. 140 W 57th St SUITE 3D New York NY NEW YORK 10019 212-582-1199 DELAWARE IRX Therapeutics Inc Corporation true Jeffrey Hwang c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 3D New York NY NEW YORK 10019 Executive Officer John W. Hadden c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 3D New York NY NEW YORK 10019 Director John W. Hadden II c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 3D New York NY NEW YORK 10019 Executive Officer Director Ferid Murad c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 3D New York NY NEW YORK 10019 Director John T. Spitznagel c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 3D New York NY NEW YORK 10019 Director Lawrence M. Wolf c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 3D New York NY NEW YORK 10019 Director Biotechnology Decline to Disclose 06 false 2012-05-15 false true true false 0 1500000 1500000 0 false 105 0 0 50000 true false IRX Therapeutics, Inc. /s/ Jeffrey Hwang Jeffrey Hwang CFO 2012-05-30